December 2017 Newsletter
December 2017 Newsletter
On behalf of the ALTG and esteemed committee members, I am honoured to address our membership as President of the Australasian Lung Cancer Trials Group (ALTG). I am committed to extending research in lung cancer trials and amplifying the well-informed voice of our consumers amidst the chaos of a very complex and challenging health care environment and funding landscape.
Never before has it been so important that we as researchers and practitioners maintain confidence and foster intellectual health so we can continue to be respected and recognized as leaders in this challenging health care landscape. Guided by our scientific and management committees and with the support of our collaborative partners, we are committed to provide strategic vision and operational leadership to all aspects of the lung cancer trials we undertake.
As 2018 quickly comes to a close, I personally reflect on the successful achievements of the year; the initiation of a record 6 clinical trials in various stages which enrolled over 100 patients in the areas of NSCLC, SCLC, and Mesothelioma; global participation in clinical trials in the areas of NSCLC and Supportive Palliative Care; our second Preceptorship and record attendance at the ALTG Symposium.
I’m confident that 2019 will hold similar successes, events and new clinical trials and I encourage you to play an active role in the ALTG by considering committee positions, sub group participation, engaging with our consumer groups, and most importantly—sharing your skills!
We wish you an enjoyable holiday season and look forward to the year ahead.
Associate Profession Nick Pavlakis
ALTG News / Events report
ALTG Preceptorship in Lung Cancer:
The third ALTG Preceptorship in Lung Cancer was held on the 22 – 23 September at the Intercontinental Melbourne the Rialto. The one and a half day workshop intended for trainees and oncology registrars included 34 attendees, including 3 from New Zealand. There were 6 preceptor groups led by senior ALTG members. It was an extremely successful meeting and was considered valuable for educating and mentoring by all participants. We encourage all trainees and registrar’s to apply for the forth Preceptorship with the confirmed dates on the 24 – 25 August 2018.
ALTG Lung Cancer Symposium:
The ALTG Lung Cancer Symposium held on 25 November, is the second education activity held by the group and is intended for healthcare professionals with an interest in lung cancer management. The meeting was chaired by past president Associate Professor Paul Mitchell and two international speakers; Professor Rolf Stahel from Switzerland and Professor Natasha Leighl from Canada. 144 delegates attended the Symposium and the ALTG also hosted a Shine a Light on Lung Cancer dinner on 24 November which attracted 121 guests. $2,500 was raised on the night and will be donated to lung cancer research. We look forward to growing the symposium next year with a date to be announced soon.
ALTG Members Meeting:
Thank you to those members who attended the ALTG Members Meeting held on the 24th November at the Sydney Westin Hotel, as part of the ALTG Lung Cancer Symposium 2017.
Meeting minutes can now be accessed online: http://altg.com.au/members-area/meetings/
Promotions – Cough in lung cancer – a health professional survey
ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.
The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer
Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.
We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.
Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.
This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).
For more information, please contact Dr Tim Luckett via firstname.lastname@example.org or 02 9514 4861.
Lung Cancer / LFA News
A warm welcome to Janet Moore, our new General Manager of Research. Janet is a registered nurse, holds an MBA and has over ten years of experience in the research field. Prior to joining the Lung Foundation Australia, she managed an early phase research unit in oncology for the University of Cambridge in the United Kingdom and worked as the General Manager for Icon Cancer Foundation, overseeing the clinical trial portfolio. She has extensive healthcare management experience in complex tertiary healthcare environments and primary health.
The ALTG portfolio of clinical trials has seen significant growth. Since 2015 over 7 trials in various phases have been triggered enrolling over 100 patients. The website will be updated in January 2018 with the group’s current portfolio of active and completed trials, and ALTG-endorsed studies led by other groups, with ALTG support.
The Management Advisory Committee (MAC) approved 25 new membership applications at the MAC meeting held as part of the ALTG Symposium. There are currently 649 active members of the ALTG. 2018 will see a new project focused on a review of member details and specialty areas with the goal to streamline our communications. In the meantime please help us to maintain current member details in our database and notify Sara of any changes to your contact information, membership and/or communication preferences.